Acadia Healthcare Company, Inc. (NASDAQ:ACHC) updated its FY17 earnings guidance on Tuesday. The company provided earnings per share guidance of $2.23-2.25 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $2.44. The company issued revenue guidance of $2.82-2.83 billion, compared to the consensus revenue estimate of $2.87 billion.

Several research firms have recently weighed in on ACHC. Mizuho lifted their price target on shares of Acadia Healthcare from $57.00 to $60.00 and gave the company a buy rating in a research note on Friday, July 28th. BMO Capital Markets began coverage on shares of Acadia Healthcare in a research note on Monday, October 16th. They set an outperform rating and a $52.00 price target for the company. Craig Hallum reaffirmed a buy rating and set a $65.00 price target (up previously from $52.00) on shares of Acadia Healthcare in a research note on Monday, July 31st. BidaskClub raised shares of Acadia Healthcare from a hold rating to a buy rating in a research note on Saturday, July 1st. Finally, Zacks Investment Research downgraded shares of Acadia Healthcare from a hold rating to a sell rating in a research note on Monday, October 2nd. Two equities research analysts have rated the stock with a sell rating, two have assigned a hold rating, ten have issued a buy rating and one has issued a strong buy rating to the stock. The company currently has a consensus rating of Buy and an average target price of $57.64.

Shares of Acadia Healthcare Company, Inc. (NASDAQ ACHC) traded down 1.28% during trading on Tuesday, reaching $44.12. 1,159,174 shares of the company were exchanged. The stock has a market capitalization of $3.88 billion, a P/E ratio of 484.84 and a beta of 1.07. The firm has a 50-day moving average price of $45.59 and a 200-day moving average price of $46.34. Acadia Healthcare Company, Inc. has a 1-year low of $32.54 and a 1-year high of $54.34.

Acadia Healthcare (NASDAQ:ACHC) last released its earnings results on Thursday, July 27th. The company reported $0.66 earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of $0.65 by $0.01. The company had revenue of $715.90 million for the quarter, compared to analyst estimates of $717.38 million. Acadia Healthcare had a net margin of 0.30% and a return on equity of 8.69%. The firm’s quarterly revenue was down 5.4% on a year-over-year basis. During the same period in the prior year, the business earned $0.73 EPS. Equities research analysts predict that Acadia Healthcare Company, Inc. will post $2.44 earnings per share for the current fiscal year.

In other news, EVP Christopher L. Howard sold 53,713 shares of the firm’s stock in a transaction on Tuesday, August 22nd. The shares were sold at an average price of $50.69, for a total value of $2,722,711.97. Following the sale, the executive vice president now directly owns 147,286 shares in the company, valued at approximately $7,465,927.34. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, President Brent Turner sold 206,252 shares of the firm’s stock in a transaction on Tuesday, August 22nd. The shares were sold at an average price of $50.69, for a total transaction of $10,454,913.88. Following the completion of the sale, the president now owns 81,106 shares in the company, valued at $4,111,263.14. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 3,085,693 shares of company stock worth $157,729,099. 11.10% of the stock is owned by company insiders.

ILLEGAL ACTIVITY NOTICE: “Acadia Healthcare Company, Inc. (ACHC) Updates FY17 Earnings Guidance” was originally posted by American Banking News and is owned by of American Banking News. If you are accessing this piece on another domain, it was copied illegally and republished in violation of United States and international copyright and trademark laws. The legal version of this piece can be accessed at https://www.americanbankingnews.com/2017/10/24/acadia-healthcare-company-inc-achc-updates-fy17-earnings-guidance.html.

Acadia Healthcare Company Profile

Acadia Healthcare Company, Inc is a provider of behavioral healthcare services, with operations in the United States and the United Kingdom. The Company focuses on acquiring and developing behavioral healthcare facilities. The Company operates through two segments: U.S. Facilities and U.K. Facilities.

Earnings History and Estimates for Acadia Healthcare (NASDAQ:ACHC)

Receive News & Ratings for Acadia Healthcare Company Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Acadia Healthcare Company Inc. and related companies with MarketBeat.com's FREE daily email newsletter.